# Science Applications International Corp: financial statements, quarterly

SAIC · Nasdaq · CIK 1571123 · [Technology](/sectors/technology.md) · fiscal year ends Jan 29

Pages: [Overview](/companies/saic.md) · [Financials](/companies/saic/financials.md) · [Filings](/companies/saic/filings.md) · [Insiders](/companies/saic/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/saic/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2024 (2023-11-03) | Q4 FY2024 (2024-02-02) | Q1 FY2025 (2024-05-03) | Q2 FY2025 (2024-08-02) | Q3 FY2025 (2024-11-01) | Q4 FY2025 (2025-01-31) | Q1 FY2026 (2025-05-02) | Q2 FY2026 (2025-08-01) | Q3 FY2026 (2025-10-31) | Q4 FY2026 (2026-01-30) | Q1 FY2027 (2026-05-01) | Q2 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,895](/filings/0001571123-24-000153.md) | [1,737 d](/filings/0001571123-26-000029.md) | [1,847](/filings/0001571123-25-000107.md) | [1,818](/filings/0001571123-25-000166.md) | [1,976](/filings/0001571123-25-000189.md) | [1,838 d](/filings/0001571123-26-000029.md) | [1,877](/filings/0001571123-26-000079.md) | [1,769](/filings/0001571123-26-000133.md) | [1,866](/filings/0001571123-25-000189.md) | [1,750 d](/filings/0001571123-26-000029.md) | [1,906](/filings/0001571123-26-000079.md) | [1,880](/filings/0001571123-26-000133.md) |
| Cost of revenue | $m | [1,666](/filings/0001571123-24-000153.md) | [1,545 d](/filings/0001571123-26-000029.md) | [1,634](/filings/0001571123-25-000107.md) | [1,608](/filings/0001571123-25-000166.md) | [1,739](/filings/0001571123-25-000189.md) | [1,606 d](/filings/0001571123-26-000029.md) | [1,668](/filings/0001571123-26-000079.md) | [1,554](/filings/0001571123-26-000133.md) | [1,639](/filings/0001571123-25-000189.md) | [1,529 d](/filings/0001571123-26-000029.md) | [1,657](/filings/0001571123-26-000079.md) | [1,641](/filings/0001571123-26-000133.md) |
| Selling, general and administrative | $m | [87.0](/filings/0001571123-24-000153.md) | [114 d](/filings/0001571123-26-000029.md) | [85.0](/filings/0001571123-25-000107.md) | [77.0](/filings/0001571123-25-000166.md) | [83.0](/filings/0001571123-25-000189.md) | [94.0 d](/filings/0001571123-26-000029.md) | [89.0](/filings/0001571123-26-000079.md) | [75.0](/filings/0001571123-26-000133.md) | [101](/filings/0001571123-25-000189.md) | [85.0 d](/filings/0001571123-26-000029.md) | [83.0](/filings/0001571123-26-000079.md) | [87.0](/filings/0001571123-26-000133.md) |
| Operating income | $m | [143](/filings/0001571123-24-000153.md) | [79.0 d](/filings/0001571123-26-000029.md) | [131](/filings/0001571123-25-000107.md) | [134](/filings/0001571123-25-000166.md) | [160](/filings/0001571123-25-000189.md) | [138 d](/filings/0001571123-26-000029.md) | [121](/filings/0001571123-26-000079.md) | [139](/filings/0001571123-26-000133.md) | [128](/filings/0001571123-25-000189.md) | [133 d](/filings/0001571123-26-000029.md) | [179](/filings/0001571123-26-000079.md) | [152](/filings/0001571123-26-000133.md) |
| Interest expense | $m | [27.0](/filings/0001571123-24-000153.md) | not reported | [34.0](/filings/0001571123-24-000086.md) | [31.0](/filings/0001571123-24-000129.md) | [32.0](/filings/0001571123-24-000153.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [21.0](/filings/0001571123-24-000153.md) | [9.0 d](/filings/0001571123-26-000029.md) | [18.0](/filings/0001571123-25-000107.md) | [19.0](/filings/0001571123-25-000166.md) | [20.0](/filings/0001571123-25-000189.md) | [9.0 d](/filings/0001571123-26-000029.md) | [18.0](/filings/0001571123-26-000079.md) | [(19.0)](/filings/0001571123-26-000133.md) | [16.0](/filings/0001571123-25-000189.md) | [14.0 d](/filings/0001571123-26-000029.md) | [30.0](/filings/0001571123-26-000079.md) | [17.0](/filings/0001571123-26-000133.md) |
| Net income | $m | [93.0](/filings/0001571123-24-000153.md) | [39.0 d](/filings/0001571123-25-000022.md) | [77.0](/filings/0001571123-25-000107.md) | [81.0](/filings/0001571123-25-000166.md) | [106](/filings/0001571123-25-000189.md) | [98.0 d](/filings/0001571123-25-000022.md) | [68.0](/filings/0001571123-26-000079.md) | [127](/filings/0001571123-26-000133.md) | [78.0](/filings/0001571123-25-000189.md) | [85.0 d](/filings/0001571123-26-000029.md) | [115](/filings/0001571123-26-000079.md) | [102](/filings/0001571123-26-000133.md) |
| Diluted EPS | $ per share | [1.76](/filings/0001571123-24-000153.md) | not reported | [1.48](/filings/0001571123-25-000107.md) | [1.58](/filings/0001571123-25-000166.md) | [2.13](/filings/0001571123-25-000189.md) | not reported | [1.42](/filings/0001571123-26-000079.md) | [2.71](/filings/0001571123-26-000133.md) | [1.69](/filings/0001571123-25-000189.md) | not reported | [2.61](/filings/0001571123-26-000079.md) | [2.38](/filings/0001571123-26-000133.md) |
| Basic EPS | $ per share | [1.79](/filings/0001571123-24-000153.md) | not reported | [1.49](/filings/0001571123-25-000107.md) | [1.59](/filings/0001571123-25-000166.md) | [2.15](/filings/0001571123-25-000189.md) | not reported | [1.43](/filings/0001571123-26-000079.md) | [2.72](/filings/0001571123-26-000133.md) | [1.70](/filings/0001571123-25-000189.md) | not reported | [2.63](/filings/0001571123-26-000079.md) | [2.41](/filings/0001571123-26-000133.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss, us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2024 (2023-11-03) | FY2024 (2024-02-02) | Q1 FY2025 (2024-05-03) | Q2 FY2025 (2024-08-02) | Q3 FY2025 (2024-11-01) | FY2025 (2025-01-31) | Q1 FY2026 (2025-05-02) | Q2 FY2026 (2025-08-01) | Q3 FY2026 (2025-10-31) | FY2026 (2026-01-30) | Q1 FY2027 (2026-05-01) | Q2 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [311](/filings/0001571123-23-000135.md) | [94.0](/filings/0001571123-25-000022.md) | [49.0](/filings/0001571123-24-000086.md) | [48.0](/filings/0001571123-24-000129.md) | [46.0](/filings/0001571123-24-000153.md) | [56.0](/filings/0001571123-26-000029.md) | [47.0](/filings/0001571123-25-000107.md) | [48.0](/filings/0001571123-25-000166.md) | [45.0](/filings/0001571123-25-000189.md) | [182](/filings/0001571123-26-000133.md) | [109](/filings/0001571123-26-000079.md) | [126](/filings/0001571123-26-000133.md) |
| Current assets | $m | [1,388](/filings/0001571123-23-000135.md) | [1,131](/filings/0001571123-25-000022.md) | [1,091](/filings/0001571123-24-000086.md) | [1,103](/filings/0001571123-24-000129.md) | [1,160](/filings/0001571123-24-000153.md) | [1,154](/filings/0001571123-26-000029.md) | [1,148](/filings/0001571123-25-000107.md) | [1,204](/filings/0001571123-25-000166.md) | [1,257](/filings/0001571123-25-000189.md) | [1,179](/filings/0001571123-26-000133.md) | [1,199](/filings/0001571123-26-000079.md) | [1,279](/filings/0001571123-26-000133.md) |
| Total assets | $m | [5,658](/filings/0001571123-23-000135.md) | [5,314](/filings/0001571123-25-000022.md) | [5,250](/filings/0001571123-24-000086.md) | [5,250](/filings/0001571123-24-000129.md) | [5,275](/filings/0001571123-24-000153.md) | [5,246](/filings/0001571123-26-000029.md) | [5,211](/filings/0001571123-25-000107.md) | [5,201](/filings/0001571123-25-000166.md) | [5,423](/filings/0001571123-25-000189.md) | [5,354](/filings/0001571123-26-000133.md) | [5,338](/filings/0001571123-26-000079.md) | [5,423](/filings/0001571123-26-000133.md) |
| Current liabilities | $m | [1,226](/filings/0001571123-23-000135.md) | [1,158](/filings/0001571123-25-000022.md) | [1,154](/filings/0001571123-24-000086.md) | [1,292](/filings/0001571123-24-000129.md) | [1,337](/filings/0001571123-24-000153.md) | [1,396](/filings/0001571123-26-000029.md) | [1,474](/filings/0001571123-25-000107.md) | [1,447](/filings/0001571123-25-000166.md) | [1,050](/filings/0001571123-25-000189.md) | [982](/filings/0001571123-26-000133.md) | [1,037](/filings/0001571123-26-000079.md) | [1,062](/filings/0001571123-26-000133.md) |
| Long-term debt | $m | [2,194](/filings/0001571123-23-000135.md) | [2,022](/filings/0001571123-25-000022.md) | [1,993](/filings/0001571123-24-000086.md) | [1,970](/filings/0001571123-24-000129.md) | [1,939](/filings/0001571123-24-000153.md) | [1,907](/filings/0001571123-26-000029.md) | [1,876](/filings/0001571123-25-000107.md) | [1,844](/filings/0001571123-25-000166.md) | [2,475](/filings/0001571123-25-000189.md) | [2,468](/filings/0001571123-26-000133.md) | [2,460](/filings/0001571123-26-000079.md) | [2,452](/filings/0001571123-26-000133.md) |
| Current portion of debt | $m | [69.0](/filings/0001571123-23-000135.md) | [77.0](/filings/0001571123-25-000022.md) | [90.0](/filings/0001571123-24-000086.md) | [197](/filings/0001571123-24-000129.md) | [220](/filings/0001571123-24-000153.md) | [313](/filings/0001571123-26-000029.md) | [405](/filings/0001571123-25-000107.md) | [448](/filings/0001571123-25-000166.md) | [12.0](/filings/0001571123-25-000189.md) | [19.0](/filings/0001571123-26-000133.md) | [26.0](/filings/0001571123-26-000079.md) | [33.0](/filings/0001571123-26-000133.md) |
| Shareholders' equity | $m | [1,828](/filings/0001571123-23-000135.md) | [1,785](/filings/0001571123-25-000022.md) | [1,759](/filings/0001571123-24-000086.md) | [1,625](/filings/0001571123-24-000129.md) | [1,612](/filings/0001571123-24-000153.md) | [1,577](/filings/0001571123-26-000029.md) | [1,505](/filings/0001571123-25-000107.md) | [1,517](/filings/0001571123-25-000166.md) | [1,512](/filings/0001571123-25-000189.md) | [1,500](/filings/0001571123-26-000133.md) | [1,423](/filings/0001571123-26-000079.md) | [1,436](/filings/0001571123-26-000133.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2024 (2023-11-03) | Q4 FY2024 (2024-02-02) | Q1 FY2025 (2024-05-03) | Q2 FY2025 (2024-08-02) | Q3 FY2025 (2024-11-01) | Q4 FY2025 (2025-01-31) | Q1 FY2026 (2025-05-02) | Q2 FY2026 (2025-08-01) | Q3 FY2026 (2025-10-31) | Q4 FY2026 (2026-01-30) | Q1 FY2027 (2026-05-01) | Q2 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [101 d](/filings/0001571123-24-000153.md) | [63.0 d](/filings/0001571123-26-000029.md) | [98.0](/filings/0001571123-25-000107.md) | [138 d](/filings/0001571123-25-000166.md) | [143 d](/filings/0001571123-25-000189.md) | [115 d](/filings/0001571123-26-000029.md) | [100](/filings/0001571123-26-000079.md) | [122 d](/filings/0001571123-26-000133.md) | [129 d](/filings/0001571123-25-000189.md) | [258 d](/filings/0001571123-26-000029.md) | [127](/filings/0001571123-26-000079.md) | [146 d](/filings/0001571123-26-000133.md) |
| Capital expenditure | $m | [4.0 d](/filings/0001571123-24-000153.md) | [11.0 d](/filings/0001571123-26-000029.md) | [6.0](/filings/0001571123-25-000107.md) | [6.0 d](/filings/0001571123-25-000166.md) | [9.0 d](/filings/0001571123-25-000189.md) | [15.0 d](/filings/0001571123-26-000029.md) | [8.0](/filings/0001571123-26-000079.md) | [7.0 d](/filings/0001571123-26-000133.md) | [9.0 d](/filings/0001571123-25-000189.md) | [8.0 d](/filings/0001571123-26-000029.md) | [9.0](/filings/0001571123-26-000079.md) | [15.0 d](/filings/0001571123-26-000133.md) |
| Dividends paid | $m | [19.0 d](/filings/0001571123-24-000153.md) | [19.0 d](/filings/0001571123-26-000029.md) | [20.0](/filings/0001571123-25-000107.md) | [19.0 d](/filings/0001571123-25-000166.md) | [18.0 d](/filings/0001571123-25-000189.md) | [18.0 d](/filings/0001571123-26-000029.md) | [19.0](/filings/0001571123-26-000079.md) | [17.0 d](/filings/0001571123-26-000133.md) | [17.0 d](/filings/0001571123-25-000189.md) | [17.0 d](/filings/0001571123-26-000029.md) | [17.0](/filings/0001571123-26-000079.md) | [16.0 d](/filings/0001571123-26-000133.md) |
| Share repurchases | $m | [103 d](/filings/0001571123-24-000153.md) | [89.0 d](/filings/0001571123-26-000029.md) | [103](/filings/0001571123-25-000107.md) | [201 d](/filings/0001571123-25-000166.md) | [121 d](/filings/0001571123-25-000189.md) | [133 d](/filings/0001571123-26-000029.md) | [142](/filings/0001571123-26-000079.md) | [110 d](/filings/0001571123-26-000133.md) | [95.0 d](/filings/0001571123-25-000189.md) | [98.0 d](/filings/0001571123-26-000029.md) | [188](/filings/0001571123-26-000079.md) | [98.0 d](/filings/0001571123-26-000133.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2023 (2022-10-28) | Q1 FY2024 (2023-05-05) | Q2 FY2024 (2023-08-04) | Q3 FY2024 (2023-11-03) | Q1 FY2025 (2024-05-03) | Q2 FY2025 (2024-08-02) | Q3 FY2025 (2024-11-01) | Q1 FY2026 (2025-05-02) | Q2 FY2026 (2025-08-01) | Q3 FY2026 (2025-10-31) | Q1 FY2027 (2026-05-01) | Q2 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [55.5](/filings/0001571123-23-000135.md) | [54.8](/filings/0001571123-24-000086.md) | [53.9](/filings/0001571123-24-000129.md) | [53.3](/filings/0001571123-24-000153.md) | [52.1](/filings/0001571123-25-000107.md) | [51.2](/filings/0001571123-25-000166.md) | [49.8](/filings/0001571123-25-000189.md) | [47.8](/filings/0001571123-26-000079.md) | [46.8](/filings/0001571123-26-000133.md) | [46.1](/filings/0001571123-25-000189.md) | [44.0](/filings/0001571123-26-000079.md) | [42.8](/filings/0001571123-26-000133.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 41,897,635 at 2026-08-21, from the cover of the [10-Q filed 2026-08-31](/filings/0001571123-26-000133.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:43 ET. No prices; not investment advice.